Home » Found Weight Loss Review: Does This GLP-1 Telehealth Program Deliver?

Reviews

Found Weight Loss Review: Does This GLP-1 Telehealth Program Deliver?

Kevin O'Shea

May 31, 2026

Updated on May 31, 2026

TLDR

Found is a telehealth weight care platform that connects you with licensed clinicians who can prescribe GLP-1 medications and other anti-obesity drugs – all from your phone.

• What it is: A membership-based, medically supervised online weight loss clinic offering GLP-1s, compounded semaglutide and tirzepatide, plus behavior coaching
• Who it’s for: Adults with a BMI of 27+ who want prescription-assisted weight loss without in-person clinic visits
• Top strengths: Broad medication formulary (15+ options), insurance acceptance, structured provider check-ins, and an engaged in-app community
• Biggest limitation: Pricing transparency is poor – you have to complete a lengthy intake quiz before seeing any numbers, and membership fees don’t cover medication costs
• Quick verdict: A solid pick if you want insurance navigation help and human-centered clinical support; a frustrating one if you value upfront pricing or want a truly hands-off experience

Why You’re Probably Here Right Now

GLP-1 medications have gone from niche diabetes treatments to cultural phenomena in about 36 months. Everyone from your coworker to your doctor is talking about semaglutide and tirzepatide. The problem? Brand-name Wegovy and Zepbound can cost over $1,000 a month out of pocket, your primary care doctor has a six-week wait, and the telehealth market is now flooded with companies promising affordable, fast access – making it genuinely hard to tell which ones are legitimate.

Found has been around since 2019, longer than most of its competitors, and has crossed the 300,000-member mark. It’s been named a top weight loss program by both Forbes and USA Today, and it’s completed a peer-reviewed outcomes study of over 66,000 participants. That’s a lot more credibility than the average “start for $49” ad you’ve been seeing on Instagram. But credibility doesn’t mean it’s the right program for everyone – and the complaint threads across Trustpilot and Reddit make it clear that Found isn’t without its rough edges.

What Found Actually Is – and Who It Targets

Found positions itself as a “medically guided weight care platform,” which in practice means it acts as a telehealth clinic: you do an intake assessment, get matched with a licensed provider trained in obesity medicine, discuss your medical history and goals, and – if you’re eligible – receive a prescription that gets shipped to your door. Monthly check-ins follow, with support available via an in-app health coach and community.

The platform targets adults who have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition like type 2 diabetes, hypertension, or sleep apnea. That’s the standard clinical threshold for anti-obesity medication eligibility, which means Found is playing by legitimate medical rules, not handing out prescriptions to anyone who clicks “get started.”

What separates Found from more bare-bones GLP-1 prescribers is its breadth. While some competitors offer one or two medications, Found’s formulary spans 15+ options – from compounded semaglutide and tirzepatide to brand-name Zepbound, Wegovy, Mounjaro, and Ozempic, plus older options like Metformin, Contrave, and Saxenda. It also offers Foundayo, its branded orforglipron option, and a newer GLP-1 microdosing program for people who want to start low and titrate slowly. That range matters because what works for one person’s biology doesn’t necessarily work for another’s.

Key Features: What Real Users Are Actually Saying

The Medication Toolkit Is a Genuine Differentiator

Multiple review aggregators and user discussions highlight Found’s wide medication options as one of its most appreciated aspects. The ability to try something other than semaglutide if GLP-1 side effects become unmanageable – or to stay on an older, cheaper option like Metformin if that’s what your insurance covers – is something patients at single-medication platforms simply don’t have. Users on Trustpilot frequently note that their provider adjusted their prescription when they hit side effects, which is a meaningful difference from “here’s your Ozempic, good luck” telemedicine.

The peer-reviewed outcomes data backs this up in a meaningful way. A 2025 study published in Obesity Science & Practice analyzed over 66,000 Found members and found that more than half achieved clinically significant weight loss (5% or greater) within 12 months, with a mean weight loss of nearly 10% at the one-year mark. Found also reports that 83% of members sustain results for at least one year, and the platform claims 1.4 million pounds lost across its membership. These aren’t cherry-picked testimonials – they come from a peer-reviewed paper, which puts Found in a different category than most telehealth weight loss competitors when it comes to credibility.

Insurance Navigation Is a Real Advantage

One of Found’s clearest differentials is that it accepts insurance – a lot of it. The platform works with BlueCross BlueShield, United Healthcare, Aetna, Cigna, Anthem, and regional plans across 40+ states. For members whose plans cover GLP-1s, this can reduce the monthly medication cost dramatically. Found also handles prior authorizations, which is genuinely useful because insurance companies notoriously drag their feet on approving weight loss medications.

Review patterns across the platform suggest that members who got insurance coverage had a much smoother experience overall. The friction of navigating prior auth on your own is real, and Found handling that process is a legitimate time saver. For people whose insurance covers clinical visits but not medication, Found also offers cash-pay options on compounded semaglutide and tirzepatide – generally the more affordable path for the uninsured.

The App, Coaching, and Community

Found’s app includes behavior tracking tools, nutrition and movement guidance, access to health coaches, and an in-app member community. The AI assistant (called Aimee) gets positive mentions across reviews from users who appreciate on-demand responses between scheduled provider visits. Health coaches are consistently praised in reviews from people who actually engage with them, with common feedback being that the coaching feels personalized rather than scripted.

That said, a recurring theme in negative reviews is that support quality varies. Some users report excellent, responsive providers – others describe feeling like they fell through the cracks when needing a medication refill, a prescription adjustment, or an urgent response. App store reviews and Trustpilot comments contain a consistent thread of frustration from members who couldn’t get timely help during critical moments in their treatment, like running out of medication or experiencing side effects that needed rapid attention. The support experience seems highly dependent on your assigned provider and coach, which is a meaningful inconsistency for a platform marketed around personalized care.

Pricing and Value: The Transparency Problem

This is where things get complicated – and where Found takes some of its most justified criticism. Found does not display its pricing publicly on the main website. To see what you’ll actually pay, you have to complete a full intake assessment first. Multiple reviewers across Trustpilot and third-party review sites note this as frustrating, and a 2024 Mira Health analysis specifically flagged it as one of Found’s biggest downsides.

When pricing does become visible, it comes in three layers: a membership fee for clinical access and support, medication costs (billed separately), and in some cases lab fees if bloodwork is required before prescribing. The membership component varies depending on whether you’re using insurance or paying cash, and whether your plan includes video visits. One Trustpilot reviewer described signing up through insurance for video visits – only to have the structure change in a way that increased their costs, prompting them to revoke their recommendation of the program.

For context, brand-name GLP-1s like Wegovy and Zepbound typically start around $650/month through Found without insurance, while Ozempic and Mounjaro are in the $1,100/month range. Compounded semaglutide and tirzepatide come in at substantially lower price points. The compounded route is where most budget-conscious users land.

Found periodically runs promotions – including up to $100 off membership plans – and a free insurance check is available without completing full signup, which partially addresses the transparency gap. But compared to competitors like Hims & Hers, which publish flat all-in pricing upfront, Found’s layered cost structure can feel like fine print hunting.

Who Found Is Best For

Found makes the most sense for a specific type of user. If you have insurance that covers obesity treatment and you want a platform that will do the legwork of navigating prior authorizations, Found is genuinely well-suited to that task – it handles the insurance process better than most telehealth competitors. If you’ve tried GLP-1s before and had side effects that led to switching medications, the broad formulary means Found can accommodate that flexibility. If you want actual human support – a coach to message, a provider who knows your file, a community of people on similar journeys – Found’s infrastructure is built around that model.

People who have experienced chronic weight struggles and want something more clinical than a meal-planning app will find the structure here meaningful. Members who’ve tried everything and needed medically supervised help are consistently the most satisfied voice in Found’s review profile.

Who Should Look Elsewhere

If upfront, transparent pricing is a dealbreaker for you – and reasonably so – Found’s approach will frustrate you before you ever place a first order. Competitors like Hims & Hers publish clear all-in costs without requiring intake completion, which is a meaningfully different philosophy. If you want fast, minimal-friction access to compounded semaglutide with no coaching layer, there are leaner options in the market.

Found also isn’t the right pick if you’re not in one of its supported states or if your insurance won’t cover any component of the program. Some users report signing up, paying the upfront consultation fee, and then discovering through the provider assessment that the medication they expected to receive either wasn’t appropriate for them or would cost significantly more than anticipated. One Trustpilot reviewer specifically described paying $129 upfront and being told the requested medication wouldn’t be effective – with $35 retained as a non-refundable consultation fee after they cancelled. That kind of experience, though not universal, appears often enough in the review ecosystem to warrant awareness.

It’s also worth noting that a 2025 Stat News investigation flagged the GLP-1 microdosing trend – which Found joined alongside Noom and Hims – as lacking robust clinical evidence for efficacy at low doses. If that program appeals to you, go in with eyes open that the evidence base is thinner than for standard therapeutic doses.

Found Weight Loss Review: Who Wins and Who Doesn’t

Found has done a lot of things right. Its clinical credibility is real – peer-reviewed outcomes data, leadership from obesity medicine specialists, American Heart Association Innovators’ Network membership, and a formulary that outpaces most competitors. For people who need insurance navigation and genuinely personalized medical oversight, Found delivers where pure medication-subscription services fall short.

But it’s not without real flaws. The pricing transparency issue is a legitimate problem, not a technicality. In a market where some competitors make it easy to see total monthly costs before entering a sales funnel, Found’s quiz-first approach can feel like it’s designed to build psychological investment before revealing the bill. The support quality inconsistency is also notable – members who get a great provider and coach describe it as life-changing, while those who fall into slower communication lanes describe a maddening experience that undercuts the platform’s core value proposition.

The people who get the most out of Found tend to be those who engage fully – use the coaching, show up to check-ins, participate in the community, and communicate proactively with their provider. This isn’t a set-it-and-forget-it medication delivery service. It’s a program, and programs require participation. If that’s what you want from a weight care platform, Found is genuinely among the more serious, clinically grounded options in the telehealth space. If you want simple, fast, and cheap, you’ll find better-matched options elsewhere.

What’s your experience been with telehealth weight care programs – do you think the insurance-navigation benefit is worth the added complexity, or is transparent upfront pricing the non-negotiable for you?

FAQ

Is Found a legitimate medical service or just another weight loss app?

Found is a licensed telehealth platform that employs board-certified clinicians trained in obesity medicine. It’s LegitScript certified and has published peer-reviewed outcomes research in Obesity Science & Practice. It’s not an app that sells supplements – it operates as a medical clinic and can only prescribe medications to patients who are clinically eligible.

How much does Found cost per month?

Found doesn’t display its full pricing publicly before you complete an intake quiz, which is a common frustration. Costs include a membership/clinical fee plus separate medication costs. Brand-name GLP-1s typically range from around $650 to over $1,100 per month without insurance; compounded semaglutide and tirzepatide come in significantly lower. If your insurance covers GLP-1s, your out-of-pocket costs could be just a copay for covered visits.

Does Found accept insurance?

Yes – Found is one of the few telehealth weight care platforms that actively works with major insurers including Aetna, United Healthcare, BlueCross BlueShield, Cigna, and Anthem, among others. Coverage varies by state and plan. Found offers a free insurance check tool so you can see what’s covered before committing.

What medications can Found prescribe?

Found’s formulary includes over 15 medications, including compounded semaglutide (similar active ingredient as Ozempic and Wegovy), compounded tirzepatide (similar to Mounjaro and Zepbound), brand-name Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, Metformin, Contrave, and its own branded orforglipron called Foundayo. The prescribing decision rests entirely with your assigned provider based on your health profile.

How long does it take to get started with Found?

Found states that most members can begin treatment within a week of completing their assessment, assuming they’re eligible and no lab work is required. If prior authorization from your insurance is needed, that process can add time. Some members report delays when lab review is required before prescribing.

Can I cancel Found at any time?

Found’s cancellation policy has drawn complaints in some reviews, particularly around non-refundable consultation fees. Users should review the current refund and cancellation policy carefully before signing up, as at least one plan version retained fees even when users decided not to move forward after a consultation.

How does Found compare to Ro or Hims & Hers for weight loss?

Found’s key advantages are broader medication options and insurance navigation support. Ro has a strong app experience and also accepts insurance. Hims & Hers is cash-pay only but offers more transparent upfront pricing. For someone who wants the most clinical support and insurance optimization, Found generally edges out competitors. For someone who wants simplicity and clear pricing, Hims & Hers or leaner compounders may be a better fit.

Is the GLP-1 microdosing program from Found worth trying?

Found launched a GLP-1 microdosing program in late 2025 alongside competitors like Noom. Independent health journalists and physicians have noted there’s currently no robust clinical evidence that sub-therapeutic GLP-1 doses produce meaningful weight loss outcomes. It may suit people who are side-effect-sensitive and want to start slowly, but the evidence base for standard therapeutic doses is considerably stronger.